Starpharma (ASX:SPL) report their revenue is up 142 per cent to $6.56 million.
The increase in revenue reflects the AstraZeneca $4.3 million development milestone.
The company still reported loss after tax is $14.7 million from the expense of all research and development expenditure and patenting costs associated with VivaGel® and DEP® programs.
Shares in Starpharma (ASX:SPL) are trading 5.6 per cent higher at $1.41.
10 Mar 2021 - Afterpay’s (ASX:APT) subsidiary, Clearpay Europe, has completed its acquisition of Pagantis SAU and PMT Technology SLU, collectively known as Pagantis.
10 Mar 2020 - Gold producer West African Resources, (ASX:WAF) is pleased to announce it has completed all construction activities and has started processing ore through the milling and CIL circuits at its Sanbrado Gold Project, Burkina Faso.
20 Apr 2021 - Supermarket operator Woolworths (ASX:WOW) has upgraded its stake from 50 per cent to 75 per cent in data analytics specialist Quantium.The company has splashed $223 million to become Quantium’s majority stakeholder, according to Woolworth’s announcement today.